Follow-On Biologics Legislation Could Save Billions Of Dollars, According To CBO Legislation (S 1695) that would create an FDA approval pathway for follow-on biologics would reduce federal
health care spending by $5.9 billion and national spending on biotechnology
drugs by $25 billion over the next 10 years, according to a
Source: www.medicalnewstoday.com
# posted by Network @ 11:00 AM
